STAT+: FDA pilot offers generative AI medical devices a path to patients before they are authorized

AI products from Cadence and Limbic are among four devices recently accepted into the FDA’s TEMPO pilot that will allow digital health companies to release products without marketing authorization.

Original reporting by STAT · Mario Aguilar. GridIndex is an aggregation and intelligence layer — full credit to the original publisher.